Women lack reliable breast cancer (BC) screening methods, as 50% of BCs are detected in a late-stage. At The Blue Box, we've developed a radiation-free, pain-free, low-cost device detecting BC in urine with 88.33%. This outperforms mammography by 15% across all age groups and by 30% for women under 50. By 2025, we aim to introduce this solution in gynecology clinics through a software-driven business model.